RxDoctor Payments DataLook up a doctor →

Erica Hobson

Acute Care · Irvine, CANPI 1124652805

Payments from drug & device makers

$9,467in general payments, 2019–2025

Across 416 payments — averaging $22.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$832
  • AstraZeneca$616
  • E.r. Squibb & Sons, L.L.C.$577
  • Pfizer$508
  • Merck$472
  • Incyte Corporation$466
  • plus $6K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis40$832
AstraZeneca(2 entities)24$616
E.r. Squibb & Sons, L.L.C.26$577
Pfizer33$508
Merck24$472
Incyte Corporation17$466
GSK16$341
Beigene USA, Inc.11$339
Bristol Myers Squibb17$330
Astellas Pharma US Inc15$330
Sobi, Inc6$323
AbbVie11$302
Eisai Inc.12$259
Bayer13$255
Johnson & Johnson10$249
Amgen9$204
Seagen Inc.9$199
Pharmacyclics LLC, An Abbvie Company9$190
Gilead(2 entities)9$185
Puma Biotechnology, Inc.6$167
Daiichi Sankyo Inc.7$165
Regeneron Healthcare Solutions, Inc.2$147
Lilly USA, LLC6$133
Takeda Pharmaceuticals U.S.A., Inc.5$129
Taiho Oncology, Inc.5$126
EMD Serono, Inc.5$120
Sanofi6$112
Dendreon Pharmaceuticals LLC3$88
Emmaus Medical, Inc.4$79
Mirati Therapeutics, Inc.3$72
Boehringer Ingelheim3$72
Rigel Pharmaceuticals, Inc.4$70
Karyopharm Therapeutics Inc.3$66
Kyowa Kirin, Inc.3$63
Morphosys, US Inc.3$62
Genentech USA, Inc.2$59
Blueprint Medicines Corporation2$48
Octapharma USA, Inc.2$47
Pharmacosmos Therapeutics Inc.2$46
AVEO Pharmaceuticals, Inc.2$43
Dova Pharmaceuticals2$41
Epizyme, Inc.2$40
Servier Pharmaceuticals LLC2$39
Array Biopharma Inc2$34
Pharmaessentia USA Corporation1$34
Adaptive Biotechnologies Corporation1$31
Stemline Therapeutics Inc.1$27
GE HealthCare1$27
G1 Therapeutics, Inc.1$25
Genmab U.S., Inc.1$24
Coherus Oncology, Inc.1$24
Ipsen Biopharmaceuticals, Inc1$23
Agios Pharmaceuticals, Inc.1$22
Myriad Genetic Laboratories, Inc.1$21
Jazz Pharmaceuticals Inc.1$21
Sun Pharmaceutical Industries Inc.1$21
Tempus AI, Inc1$21
Tersera Therapeutics LLC1$18
Recordati_rare_diseases_inc.1$18
Chiesi USA, Inc.1$17

How this compares

$9,467 in reported general payments places this provider in the 95th percentile of 1,153 acute care providers in California.

See all acute care providers in California

Other acute care in Irvine

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →